Support for S3 ad restriction changes

The Australian Self Medication Industry has announced its support for the TGA’s commitment to change restrictions on the advertising of S3 medicines ASMI also says it supports the establishment of a working group that will proactively identify prescription medicines suitable for downscheduling to pharmacist-only and over-the-counter access (‘switch’). ASMI has long advocated a relaxation of

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Leading the world
Next Codeine claims and counter-claims